Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -24.00 (-1.91%)
Bid:
1,232.00
Ask:
1,242.00
Spread: 10.00 (0.812%)
Market Cap: £564.58m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Block Listing Application

12 May 2025 15:59

RNS Number : 3228I
Cohort PLC
12 May 2025
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

 

 

12 May 2025

 

 

 

 

 

 

COHORT PLC

("Cohort", "the Company" or "the Group")

 

Block Listing Application

The Company announces that an application has been made to the London Stock Exchange for a total of 1,825,000 ordinary shares of 10 pence each in the Company (the "Shares") to be admitted to trading on AIM. It is expected that admission will be granted on 14 May 2025.

These Shares are being reserved under a block listing and will be issued from time to time under the terms of the following schemes:

Scheme

No. of Shares under block listing application

Company Share Option Plan

 

1,500,000

Savings Related Share Option Scheme

325,000

 

When issued, the Shares will rank pari passu with the existing ordinary shares of 10 pence each in the capital of the Company.

 

 

 

ENDS

 

 

For further information please contact:

Cohort plc

0118 909 0390

Andrew Thomis, Chief Executive

 

Simon Walther, Finance Director

 

Raquel McGrath, Company Secretary and General Counsel

 

 

 

 

Investec Bank Plc (Financial Adviser, Nominated Adviser, and Corporate Broker)

020 7597 5970

Christopher Baird, Carlton Nelson, Charlotte Young

 

 

 

 

 

MHP

07817 458804

Reg Hoare, Ollie Hoare, Hugo Harris

Cohort@mhpgroup.com

 

 

 

NOTES TO EDITORS 

Cohort plc (www.Cohortplc.com) is the parent company of seven innovative, agile and responsive businesses based in the UK, Australia, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total over 1,500 core staff there and at its other operating company sites across the UK, Australia, Germany and Portugal.

The Group is split into two segments - Communications and Intelligence, and Sensors and Effectors:

Communications and Intelligence

EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.ptEM Solutions designs, assembles, tests, and supports satellite communications on-the-move terminals for defence and government customers. It also provides high-end broadband radio transceivers and other RF Subsystems such as low noise receivers and solid-state high-power transmitters for defence and commercial customers. Acquired by Cohort in January 2025. www.emsolutions.com.au MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services and training support. Acquired by Cohort in August 2006. www.mass.co.ukMCL designs, sources and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

Sensors and Effectors

Chess Dynamics offers surveillance, tracking and fire-control systems to the defence and security markets. Chess has been part of the Group since December 2018.  www.chess-dynamics.com ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de SEA delivers and supports technology-based products primarily for naval defence customers alongside specialist research and training services. Acquired by Cohort in October 2007. www.sea.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSBSGDULUBDGUD
Date   Source Headline
16th Jul 20257:00 amRNSFinal Results
11th Jul 20259:00 amRNS-RInvestor Presentation
11th Jul 20257:00 amRNSNotice of Results
9th Jul 202512:11 pmRNSHolding(s) in Company
1st Jul 202511:00 amRNSTotal Voting Rights
29th May 20257:00 amRNSFull Year Trading Update
12th May 20253:59 pmRNSBlock Listing Application
6th May 20252:00 pmRNS-RContract Win (Replacement)
1st May 20259:00 amRNS-RContract win
1st May 20257:00 amRNSTotal Voting Rights
24th Apr 202512:12 pmRNSDirector/PDMR Shareholding
9th Apr 20253:05 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:41 amRNSBlock Listing Six Monthly Return
1st Apr 20259:58 amRNSTotal Voting Rights
31st Mar 202512:53 pmRNSDirector/PDMR Shareholding
3rd Mar 202512:34 pmRNSTotal Voting Rights
24th Feb 20252:57 pmRNSBlock Listing Six Monthly Return
21st Feb 20252:18 pmRNSDirector/PDMR Shareholding
12th Feb 202511:00 amRNS-RInvestor Presentation via Investor Meet Company
12th Feb 20257:00 amRNSMASS wins extension for JCAST training contract
10th Feb 20257:00 amRNS-RCohort presentation at Shares Spotlight Event
5th Feb 20257:00 amRNS-RInvestor Presentation via Engage Investor
3rd Feb 20255:00 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSCompletion of EM Solutions Acquisition
24th Jan 20257:00 amRNS-RInvestor Presentation
20th Jan 20257:30 amRNSCompletion date of EM Solutions Acquisition
14th Jan 20257:00 amRNSInterim Report 2024
9th Jan 20257:00 amRNSContract Win
6th Jan 202511:25 amRNSHolding(s) in Company
2nd Jan 20254:44 pmRNSTotal Voting Rights
24th Dec 20248:30 amRNSREVISED COMPLETION OF ACQUISITION
16th Dec 20249:52 amRNSHolding(s) in Company
11th Dec 20242:00 pmRNSHalf Year Results (Replacement)
11th Dec 20247:00 amRNSHalf Year Results
2nd Dec 20242:45 pmRNSTotal Voting Rights
28th Nov 202410:00 amRNSNotice of Half Year Results
21st Nov 202411:26 amRNSResult of the Placing
21st Nov 202411:17 amRNSResult of the Retail Offer
21st Nov 20247:01 amRNSProposed Retail Offer to raise up to £1 million
21st Nov 20247:00 amRNSProposed Placing to raise £40 million
21st Nov 20247:00 amRNSAcquisition of EM Solutions
12th Nov 20249:33 amRNSHolding(s) in Company
4th Nov 20245:42 pmRNSHolding(s) in Company
1st Nov 20245:06 pmRNSTotal Voting Rights
21st Oct 202412:18 pmRNSDirector/PDMR Shareholding
4th Oct 20243:21 pmRNSDirector/PDMR Shareholding
2nd Oct 202411:22 amRNSBlock Listing Six Monthly Return
1st Oct 202411:19 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSAGM Statement
20th Sep 202410:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.